GLP-1 nostalgia content: what the science says about these drugs

What did @whitneypassey actually say?

Straight answer: nothing. Not a single medical claim was made in this video. The transcript is entirely song lyrics and exclamations, including phrases like "see your pockets lookin' lonely" and repeated shouts of "they better hate me." There is no GLP-1 content here in any meaningful sense, no claims about semaglutide, tirzepatide, weight loss, or any health topic whatsoever.

The creator's own caption confirms the intent: "Can we please bring 2020-2022 TikTok back? Miss the dancing era!" This is a nostalgia post about early TikTok dance culture, not a health video. It has been categorized under GLP-1 content, but the transcript contains zero relevant substance to evaluate from a clinical standpoint.

Does the science back this up?

There is nothing to evaluate scientifically. No claims were made. However, since this video is tagged in a GLP-1 context and reaches a health-adjacent audience, it is worth grounding readers in what the actual science on GLP-1 receptor agonists looks like, independent of anything said here.

GLP-1 receptor agonists like semaglutide and tirzepatide have a substantial evidence base. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% body weight reduction over 72 weeks. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed semaglutide 2.4mg produced roughly 14.9% weight loss versus 2.4% with placebo. These are real, peer-reviewed numbers, not marketing copy.

What did they get wrong (or right)?

This is almost an unanswerable question given the content. The creator got nothing wrong about GLP-1 medications because they said nothing about GLP-1 medications. They also got nothing right about them, for the same reason.

What is worth flagging is a pattern this video represents: health platforms sometimes capture non-health content under medical categories, which can create a misleading impression that a popular creator is endorsing or discussing a treatment when they are simply dancing. Audiences scrolling through a health feed may absorb implied association between a creator and a drug category without any actual information being transmitted. That is its own kind of misinformation risk, even if unintentional. No blame to the creator here. The categorization is the issue.

What should you actually know?

If you landed here looking for real information on GLP-1 medications, here is what matters. These drugs work by mimicking a gut hormone that signals fullness and slows gastric emptying. They are not magic. They require consistent use, and weight often returns after stopping, as documented by Wilding et al. in a 2022 follow-up published in Diabetes, Obesity and Metabolism.

Common side effects include nausea, vomiting, and constipation, particularly during dose escalation. Rare but serious risks include pancreatitis and, in rodent studies, thyroid C-cell tumors, though the human relevance of that finding remains under review. Anyone considering these medications should have a conversation with a licensed clinician who can review their full medical history, not take cues from a TikTok dance video that was never about medicine in the first place.